Hospital
Newman Memorial County Hospital
Newman Memorial County Hospital was paid $1.71M by Medicaid between Jan 2018 and Nov 2024, across 85 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
33Billing provider infoNEWMAN MEMORIAL COUNTY HOSPITAL
EMPORIA, KS 66801
EMPORIA, KS 66801
33aNPI1245643576assigned 06/04/2014
33bProvider typeCritical Access Hospital
28Total paid$1.71M
24GClaims76,992
24DCodes billed85
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Kansas
Rank by total paid#1 of 74
Median peer was paid$11K
This provider vs. median155×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,004 | $281K | |
| 2019 | 11,536 | $266K | |
| 2020 | 8,955 | $195K | |
| 2021 | 11,623 | $234K | |
| 2022 | 11,922 | $298K | |
| 2023 | 11,869 | $241K | |
| 2024incomplete | 7,083 | $191K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 11,619 | 9,610 | $474K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 24% | 8,091 | 1,602 | $411K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 6,317 | 4,864 | $212K |
| 80053 | Comprehensive metabolic panel | 6.1% | 9,976 | 9,056 | $104K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.2% | 630 | 616 | $89K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.7% | 1,474 | 1,317 | $62K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.3% | 763 | 630 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 1,478 | 712 | $31K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 697 | 601 | $30K |
| 85027 | 1.4% | 2,563 | 2,361 | $25K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 5,173 | 4,666 | $23K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 1,066 | 943 | $23K |
73 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 2,083 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 125 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,313 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 332 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 384 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 501 | $9K |
| 62323 | <1% | 70 | $9K | |
| 82728 | <1% | 388 | $7K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 58 | $7K |
| G0378 | Hospital observation service, per hour | <1% | 73 | $6K |
| 99285 | Emergency room visit (most serious) | <1% | 98 | $5K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 95 | $5K |
| 85007 | <1% | 1,605 | $5K | |
| 84439 | <1% | 283 | $4K | |
| 87632 | <1% | 29 | $4K | |
| 84484 | <1% | 450 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 87 | $3K |
| 81001 | <1% | 941 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 730 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 77 | $3K |
| 87807 | <1% | 109 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 63 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 128 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 32 | $2K |
| 83880 | <1% | 97 | $2K | |
| 83690 | <1% | 215 | $2K | |
| 93296 | <1% | 80 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 25 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 19 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 17 | $1K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 29 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 85 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 101 | $1K |
| 84145 | <1% | 56 | $992.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 98 | $938.47 |
| 81025 | <1% | 89 | $852.97 | |
| 83655 | <1% | 40 | $743.65 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 60 | $638.91 |
| 87040 | <1% | 53 | $607.51 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 291 | $551.51 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 492 | $544.89 |
| 80061 | Lipid panel | <1% | 48 | $527.51 |
| 86140 | <1% | 48 | $475.93 | |
| 85610 | <1% | 170 | $472.13 | |
| 85730 | <1% | 113 | $318.68 | |
| 87186 | <1% | 35 | $317.98 | |
| 87077 | <1% | 42 | $301.45 | |
| 83605 | <1% | 49 | $257.84 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,090 | $255.81 |
| 87486 | <1% | 29 | $255.52 | |
| 87581 | <1% | 29 | $255.52 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 123 | $253.46 |
| 83735 | <1% | 29 | $167.62 | |
| 94761 | <1% | 16 | $120.74 | |
| 82803 | <1% | 15 | $107.30 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $105.20 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 562 | $99.83 |
| 87147 | <1% | 14 | $87.55 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 130 | $82.92 |
| 81003 | <1% | 36 | $78.46 | |
| 87070 | <1% | 14 | $74.52 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 129 | $69.37 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 97 | $60.95 |
| 87205 | <1% | 13 | $49.51 | |
| 82947 | <1% | 84 | $33.03 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 70 | $31.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 22 | $31.09 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 16 | $25.75 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 20 | $23.20 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 51 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 16 | $0.00 |
| A9270 | Non-covered item or service | 0% | 101 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRENCH, HOLLY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Newman Memorial County Hospital | Emporia, KS | $6.98M |
| Newman Memorial County Hospital | Emporia, KS | $2.37M |
| Newman Memorial County Hospital | Emporia, KS | $215K |
| Newman Memorial County Hospital | Emporia, KS | $108K |
| Newman Memorial County Hospital | Emporia, KS | $7K |
| Newman Memorial County Hospital | Emporia, KS | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.